FDA Approved: PAZOPANIB — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's pazopanib ANDA 219034, a generic version of pazopanib. It is indicated for unresectable or metastatic renal cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

ORIG AP for PAZOPANIB (PAZOPANIB)